Anatara Lifesciences (ASX:ANR) Provides GaRP-IBS Trial Update
Anatara Lifesciences pauses recruitment for the GaRP-IBS trial, with pivotal results expected in March 2025 and a Share Purchase Plan closing soon.
Category: Healthcare
Oncosil Medical Ltd (ASX: OSL) Completes $1 Million Share Purchase Plan
Oncosil Medical Ltd completes a $1 million Share Purchase Plan to finance clinical trials and manufacturing improvements.
Lunnon Metals Limited (ASX:LM8) Reports Positive Results from Lady Herial
Lunnon Metals Limited (ASX:LM8) announces positive drilling results from Lady Herial, confirming significant gold mineralisation and enhancing its resource outlook.
Vulcan Energy (ASX: VUL) Completes €100m Placement for Lionheart Project
Vulcan Energy completes a €100m placement to fund its transformative Lionheart Project, enhancing its lithium and renewable energy initiatives.
Vulcan Energy (ASX: VUL) Secures EIB Financing Approval
Vulcan Energy secures EIB Board approval for up to €500 million funding for its lithium project in Germany.
BCAL Diagnostics Limited (ASX:BDX) Achieves NATA Accreditation
BCAL Diagnostics has achieved NATA accreditation and is on track to launch its BREASTEST® product in 2025.
Syntara Ltd (ASX:SNT) Secures A$15 Million Placement
Syntara Ltd raises A$15 million through a share placement to fund its clinical trials and strengthen its financial position.
Syntara Limited (ASX:SNT) Announces $15 Million Equity Raising
Syntara Limited (ASX:SNT) announces a $15 million equity placement to fund its clinical trial programs, primarily focusing on SNT-5505.
Aldoro Resources Limited (ASX:ARN) Confirms Niobium Mineralisation
Aldoro Resources (ASX:ARN) confirms significant niobium mineralisation at Kameelburg, marking a strong continued exploration effort.
Immutep Limited (ASX:IMM) Reports Promising Clinical Data
Immutep Limited (ASX:IMM) reveals promising data for HNSCC from the TACTI-003 trial, suggesting an effective therapy for underserved patients.